Anti-bacterial monoclonal antibodies: Back to the future?

► The failing efficacy of the antibiotics call for new treatment modalities for severe infections. ► Anti-infective monoclonal antibodies represent an attractive alternative approach. ► This field experienced many failures with single mAbs. ► The most promising approach with infectious disease mAbs is the use of cocktails.